Evidence map›Paper›PMID 31217512›Full record

ArticleScientific reports2019

Development of CS-TPP-dsRNA nanoparticles to enhance RNAi efficiency in the yellow fever mosquito, Aedes aegypti.

Ramesh Kumar Dhandapani, Dhandapani Gurusamy, Jeffrey L Howell, Subba Reddy Palli

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. EngineeredInsects · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Iranian journal of biotechnology · 2026
    Article
  9. Review
  10. Review
  11. Evaluation of dsRNA produced inFrontiers in insect science · 2026
    Article
  12. Article
  13. Article
  14. RNA Interference-Mediated Silencing ofInternational journal of molecular sciences · 2025
    Article
  15. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Preparation ofInsects · 2024
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ramesh Kumar DhandapaniDepartment of Entomology, University of Kentucky, Lexington, Kentucky, 40546, USA.
Dhandapani GurusamyDepartment of Entomology, University of Kentucky, Lexington, Kentucky, 40546, USA.
Jeffrey L HowellDepartment of Entomology, University of Kentucky, Lexington, Kentucky, 40546, USA.ORCID http://orcid.org/0000-0002-0939-8647
Subba Reddy PalliDepartment of Entomology, University of Kentucky, Lexington, Kentucky, 40546, USA. rpalli@email.uky.edu.ORCID http://orcid.org/0000-0002-0873-3247
University of Kentucky · USUniversity of Kentucky HealthCare · US

Funding

Molecular Analysis of Juvenile Hormone ActionR01GM070559 · NIGMS · UNIVERSITY OF KENTUCKY · PI PALLI, SUBBA R · 2005 to 2024
$4.1M
RNAi methods for Zika virus vector controlR21AI131427 · NIAID · UNIVERSITY OF KENTUCKY · PI PALLI, SUBBA R · 2017 to 2018
$385k
NIAID NIH HHS R21 AI131427NIGMS NIH HHS R01 GM070559
6 · The paper itself

Abstract

Mosquito-borne diseases are a major threat to human health and are responsible for millions of deaths globally each year. Vector control is one of the most important approaches used in reducing the incidence of these diseases. However, increasing mosquito resistance to chemical insecticides presents challenges to this approach. Therefore, new strategies are necessary to develop the next generation vector control methods. Because of the target specificity of dsRNA, RNAi-based control measures are an attractive alternative to current insecticides used to control disease vectors. In this study, Chitosan (CS) was cross-linked to sodium tripolyphosphate (TPP) to produce nano-sized polyelectrolyte complexes with dsRNA. CS-TPP-dsRNA nanoparticles were prepared by ionic gelation method. The encapsulation efficiency, protection of dsRNA from nucleases, cellular uptake, in vivo biodistribution, larval mortality and gene knockdown efficiency of CS-TPP-dsRNA nanoparticles were determined. The results showed that at a 5:1 weight ratio of CS-TPP to dsRNA, nanoparticles of less than 200 nm mean diameter and a positive surface charge were formed. Confocal microscopy revealed the distribution of the fed CS-TPP-dsRNA nanoparticles in midgut, fat body and epidermis of yellow fever mosquito, Aedes aegypti larvae. Bioassays showed significant mortality of larvae fed on CS-TPP-dsRNA nanoparticles. These assays also showed knockdown of a target gene in CS-TPP-dsRNA nanoparticle fed larvae. These data suggest that CS-TPP nanoparticles may be used for delivery of dsRNA to mosquito larvae.

Indexed as

AedesChitosanMosquito ControlPolyphosphatesRNA, Double-StrandedRNA InterferenceAnimalsDrug ResistanceLarvaNanoparticlesYellow FeverChitosanPolyphosphatesRNA, Double-Strandedtriphosphoric acid

Identifiers

PMID31217512
PMCPMC6584730
OpenAlexW2949059884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.